Tafinlar
(dabrafenib)dabrafenib 50 MG Oral Capsule [Tafinlar]dabrafenib 75 MG Oral Capsule [Tafinlar]
NO BLACK BOX WARNING
Dosage & administration
biomarker testing
Tafinlar clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Tafinlar prescribing information
financial assistance
Tafinlar financial assistance options
Co-pay savings program
commercial only
Learn More
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
patient education
Tafinlar patient education
Getting started on Tafinlar
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Learn More
Other resources
Learn More
people also ask
Tafinlar FAQs
How is the dosage of Tafinlar?Tafinlar is available in 2 dosages, including 50 mg Cap and 75 mg Cap
What does Tafinlar treat?Tafinlar treats Melanoma
What is Tafinlar made of?Tafinlar contains dabrafenib which is a Kinase Inhibitor
How Is Tafinlar Administered?Tafinlar is administered as a Oral Pill
What Are The Tafinlar Mechanism Of Action?Tafinlar mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 2B6 Inducers, Cytochrome P450 2C19 Inducers, Cytochrome P450 2C8 Inducers, Cytochrome P450 2C9 Inducers, Cytochrome P450 3A4 Inducers, Organic Anion Transporter 1 Inhibitors, Organic Anion Transporter 3 Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Organic Anion Transporting Polypeptide 1B3 Inhibitors or Protein Kinase Inhibitors
FAQ Data Source